Vaxcyte Inc (PCVX)

EBITDA Growth

-79.19%

Quarterly · Period ending:

PCVX logo

PCVX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-79.19%
PCVX Quarterly EBITDA YoY % (-100.17% → -79.19%)
High-resolution chart · PNG

PCVX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-79.1935%
-131.7128%
-350.2102%
-53.6418%
-29.0349%
-47.7706%
70.4379%
-24.0896%
-52.19%
-34.8012%
-134.7894%
-96.0045%
-77.4964%
-85.8607%
-176.8944%
-115.7032%
-103.2845%
-62.2391%
-34.0701%
-24.5359%
-14.2199%
15.4574%
-42.8721%
-87.8997%
-92.824%
-100.1721%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.